OSAplex capsule label record in the NIH DSLD (XYMOGEN)
The NIH Dietary Supplement Label Database lists OSAplex, a XYMOGEN capsule in the Multi-Vitamin and Mineral category, with declared label amounts for choline, silicon, vitamin D3, calcium, phosphorus and hydroxyapatite concentrate. A listing is not evidence of efficacy or approval. [1]
Automatic summary · not editorially reviewed
FROM THE ORIGINAL LABEL
A closer look at the product
- Pack contents
- 60 Packet(s) · 180 Capsule(s)
- Label serving
- 2 Capsule(s) · 1 Capsule(s)
- Servings per container
- 60
- Barcode / SKU
- 8 71149 00236 7
Ingredients & declared amounts7
Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.
| Ingredient | Amount | Per label serving |
|---|---|---|
| Choline | 60 mg | 1 Capsule(s) |
| Silicon | 3 mg | 1 Capsule(s) |
| Vitamin D3 | 50 mcg | 2 Capsule(s) |
| Calcium | 550 mg | 2 Capsule(s) |
| Phosphorus | 198 mg | 2 Capsule(s) |
| Microcrystalline Hydroxyapatite Concentrate | 2.2 Gram(s) | 2 Capsule(s) |
| Microcrystalline Hydroxyapatite | 1.32 Gram(s) | 2 Capsule(s) |
Other ingredients: Hypromellose, Water, Stearic Acid, Magnesium Stearate, Medium Chain Triglyceride Oil, Silica, Microcrystalline Cellulose, Hypromellose, Water, Water, Purified
Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.
The key findings
Record 335537 lists OSAplex, brand XYMOGEN, as a capsule in the Multi-Vitamin and Mineral category. [1]
Per labelled serving the label declares choline 60 mg, silicon 3 mg, vitamin D3 50 mcg, calcium 550 mg and phosphorus 198 mg. [1]
DSLD inclusion does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. [1]
The source at a glance
- Brand
- XYMOGEN
- Form
- Capsule
- Pack contents
- 60 Packet(s) · 180 Capsule(s)
- Label serving
- 2 Capsule(s) · 1 Capsule(s)
- Ingredients listed
- Choline · Silicon · Vitamin D3 · Calcium · Phosphorus · Microcrystalline Hydroxyapatite Concentrate · Microcrystalline Hydroxyapatite
- Record type / format
- Dietary supplement label/database record
- Scope / context
- The dietary supplement product OSAplex (XYMOGEN), capsule form, as described in the DSLD record.
- Summary based on
- Product label / database record
OSAplex record in the NIH DSLD
This is record 335537 in the NIH Office of Dietary Supplements Dietary Supplement Label Database. The label name is OSAplex and the declared brand is XYMOGEN. The label entered the database on 2025-09-25; the record notes this is not a product launch date. The database places the product in the Multi-Vitamin and Mineral category. The record describes label declarations only and supplies no independent testing, price or batch certificate.
Supporting source [1]
Declared capsule ingredients and label amounts
The label form is Capsule. Per labelled serving, the record lists choline (form ch-OSA) 60 mg, silicon (form ch-OSA) 3 mg, vitamin D3 (cholecalciferol) 50 mcg, calcium 550 mg and phosphorus 198 mg, the last two from Microcrystalline Hydroxyapatite Concentrate. It also lists that concentrate at 2.2 grams and Microcrystalline Hydroxyapatite at 1.32 grams per labelled serving. These are label facts, not personal dosing advice.
Supporting source [1]
What the OSAplex listing does not establish
Inclusion in the database does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The record contains no study, no comparison group and no outcome data, so it cannot show that the product works or is superior to anything. The ingredient names are reported as label declarations and are not expanded here into health claims.
Supporting source [1]
How to interpret this
Product label record; not evidence of efficacy or approval. The record describes label declarations only, with no independent testing, study, price or batch certificate.
Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.
Source & supporting passages
XYMOGEN · dsld.od.nih.gov
